Conference call to follow on November 22, 2022 at 9:00am ET
NEW YORK, Nov. 16, 2022 (GLOBE NEWSWIRE) — StoneX Group Inc. (NASDAQ: SNEX) today announced that it will release its fiscal 2022 fourth quarter results after the market close on Monday, November 21, 2022. Management will host a conference call on Tuesday, November 22, 2022 at 9:00 a.m. Eastern Time to review the Company’s 2022 fiscal fourth quarter results.
A live web cast of the conference call as well as additional information to review during the call will be made available in PDF form at https://www.stonex.com. Participants can also access the call via https://register.vevent.com/register/BIc54c02e6ccf34bb6b56bafdef3029edc approximately ten minutes prior to the start time. Participants may preregister for the conference call here.
For those who cannot access the live broadcast, a replay of the call will be available at https://www.stonex.com.
About StoneX Group Inc.
StoneX Group Inc., through its subsidiaries, operates a global financial services network that connects companies, organizations, traders and investors to the global market ecosystem through a unique blend of digital platforms, end-to-end clearing and execution services, high touch service and deep expertise. The Company strives to be the one trusted partner to its clients, providing its network, product and services to allow them to pursue trading opportunities, manage their market risks, make investments and improve their business performance. A Fortune-500 company headquartered in New York City and listed on the Nasdaq Global Select Market (NASDAQ:SNEX), StoneX Group Inc. and its approximately 3,600 employees serve more than 52,000 commercial, institutional, and global payments clients, and more than 370,000 retail accounts, from more than 40 offices spread across five continents. Further information on the Company is available at www.stonex.com.
CONTACT: StoneX Group Inc.
(212) 403 – 7296
- Baker Hughes Unveils New Digital Solutions for More Intelligent Operations and Cleaner Energy - January 30, 2023
- Dupixent® (dupilumab) Approved by European Commission as the First and Only Targeted Medicine Indicated for Eosinophilic Esophagitis - January 30, 2023
- The Europe Pet Food Packaging Market Size is Predicted to be Valued at US$ 5.06 billion by 2033 | Future Market Insights, Inc. - January 30, 2023